Eleftherios Chatzellis
Overview
Explore the profile of Eleftherios Chatzellis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
301
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Papadopoulou-Marketou N, Tsoli M, Chatzellis E, Alexandraki K, Kaltsas G
Cancers (Basel)
. 2024 Jun;
16(11).
PMID: 38893191
Pancreatic neuroendocrine tumors (PanNETs) and lung NETs (LNETs) represent a rare but clinically significant subgroup of neoplasms. While the majority is sporadic, approximately 17% of PanNETs and a subset of...
2.
Angelousi A, Tzoulis P, Tsoli M, Chatzellis E, Koumarianou A, Kaltsas G
Endocr Relat Cancer
. 2024 Jan;
31(4).
PMID: 38235757
Immunotherapy has revolutionised the treatment of oncological patients, but its application in various endocrine tumours is rather limited and is mainly used when conventional therapies have failed. Immune checkpoint inhibitors...
3.
Papadimitriou E, Chatzellis E, Dimitriadi A, Kaltsas G, Theocharis S, Alexandraki K
touchREV Endocrinol
. 2024 Jan;
19(2):42-53.
PMID: 38187082
Pituitary tumours (PTs) are the second most common intracranial tumour. Although the majority show benign behaviour, they may exert aggressive behaviour and can be resistant to treatment. The aim of...
4.
Alexandraki K, Angelousi A, Chatzellis E, Chrisoulidou A, Kalogeris N, Kanakis G, et al.
J Pers Med
. 2023 Feb;
13(2).
PMID: 36836538
Background: Somatostatin analogues (SSAs) are the cornerstone of treatment for carcinoid syndrome (CS)-related symptoms. The aim of this systematic review and meta-analysis is to evaluate the percentage of patients achieving...
5.
Angelousi A, Koumarianou A, Chatzellis E, Kaltsas G
Expert Rev Endocrinol Metab
. 2023 Jan;
18(1):33-52.
PMID: 36651768
Introduction: A common feature shared by most neuroendocrine tumors (NETs) is the expression on their surface of somatostatin receptors (SSTRs) that are essential for their pathophysiological regulation, diagnosis, and management....
6.
Angelousi A, Hayes A, Chatzellis E, Kaltsas G, Grossman A
Endocr Relat Cancer
. 2022 May;
29(7):R85-R103.
PMID: 35521769
Medullary thyroid carcinoma (MTC) is a rare malignancy comprising 1-2% of all thyroid cancers in the United States. Approximately 20% of cases are familial, secondary to a germline RET mutation,...
7.
Koumarianou A, Kaltsas G, Chatzellis E, Kyriakopoulos G, Kolomodi D, Alexandraki K
Endocrine
. 2021 Feb;
73(1):232-239.
PMID: 33544352
Purpose: Recent advances in the field of immunotherapy have significantly prolonged the survival of patients with aggressive carcinomas, but the role of immunotherapy in neuroendocrine neoplasms (NENs) remains to be...
8.
Xydakis A, Chatzellis E, Kolomodi D, Kaltsas G, Alexandraki K
Am J Med
. 2020 Mar;
133(9):e518-e520.
PMID: 32199809
No abstract available.
9.
Chatzellis E, Daskalakis K, Angelousi A, Tsoli M, Alexandraki K, Wachula E, et al.
Neuroendocrinology
. 2019 Oct;
110(1-2):158-160.
PMID: 31597137
No abstract available.
10.
Daskalakis K, Tsoli M, Alexandraki K, Angelousi A, Chatzellis E, Tsolakis A, et al.
Horm Metab Res
. 2019 Jul;
51(9):580-585.
PMID: 31295747
Our aim was to compare the clinical utility of Magnetic Resonance Imaging (MRI) and Endoscopic Ultrasonography (EUS) in identifying Pancreatic Neurondocrine Neoplasms (PanNENs) and monitoring size alterations in Multiple Endocrine...